468 related articles for article (PubMed ID: 15317028)
21. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.
Thai XC; Bruno-Murtha LA
Pharmacotherapy; 2006 Aug; 26(8):1183-9. PubMed ID: 16863496
[TBL] [Abstract][Full Text] [Related]
22. Clinical judgment, common sense and adverse reaction reporting.
Shapiro S
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):511-3; discussion 515-7. PubMed ID: 15317029
[No Abstract] [Full Text] [Related]
23. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.
Moro PL; Broder K; Zheteyeva Y; Walton K; Rohan P; Sutherland A; Guh A; Haber P; Destefano F; Vellozzi C
Am J Obstet Gynecol; 2011 Feb; 204(2):146.e1-7. PubMed ID: 20965490
[TBL] [Abstract][Full Text] [Related]
24. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT
Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of acupuncture and moxibustion to treat Bell's palsy according to different stages: design and protocol.
Chen X; Li Y; Zheng H; Hu K; Zhang H; Zhao L; Li Y; Liu L; Mang L; Yu S
Contemp Clin Trials; 2009 Jul; 30(4):347-53. PubMed ID: 19281871
[TBL] [Abstract][Full Text] [Related]
26. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
27. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.
Lee GM; Greene SK; Weintraub ES; Baggs J; Kulldorff M; Fireman BH; Baxter R; Jacobsen SJ; Irving S; Daley MF; Yin R; Naleway A; Nordin JD; Li L; McCarthy N; Vellozzi C; Destefano F; Lieu TA;
Am J Prev Med; 2011 Aug; 41(2):121-8. PubMed ID: 21767718
[TBL] [Abstract][Full Text] [Related]
28. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.
Hua W; Izurieta HS; Slade B; Belay ED; Haber P; Tiernan R; Woo EJ; Iskander J; Braun MM; Ball R
Pediatr Infect Dis J; 2009 Nov; 28(11):943-7. PubMed ID: 19755926
[TBL] [Abstract][Full Text] [Related]
29. Independent role of hypertension in Bell's palsy: a case-control study.
Savadi-Oskouei D; Abedi A; Sadeghi-Bazargani H
Eur Neurol; 2008; 60(5):253-7. PubMed ID: 18756090
[TBL] [Abstract][Full Text] [Related]
30. Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system.
Leroy Z; Broder K; Menschik D; Shimabukuro T; Martin D
Vaccine; 2012 Mar; 30(11):2020-3. PubMed ID: 22361303
[TBL] [Abstract][Full Text] [Related]
31. Equilibrium test findings in patients with Bell's palsy.
Watanabe T; Suzuki M
Auris Nasus Larynx; 2006 Jun; 33(2):143-7. PubMed ID: 16457977
[TBL] [Abstract][Full Text] [Related]
32. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database.
Sato K; Mano T; Niimi Y; Toda T; Iwata A; Iwatsubo T
Int J Infect Dis; 2021 Oct; 111():310-312. PubMed ID: 34492394
[TBL] [Abstract][Full Text] [Related]
33. Bell's palsy: a review of treatment using antiviral agents.
Alberton DL; Zed PJ
Ann Pharmacother; 2006 Oct; 40(10):1838-42. PubMed ID: 16968821
[TBL] [Abstract][Full Text] [Related]
34. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ;
Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118
[TBL] [Abstract][Full Text] [Related]
35. The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997.
Silvers LE; Ellenberg SS; Wise RP; Varricchio FE; Mootrey GT; Salive ME
Pharmacoepidemiol Drug Saf; 2001; 10(4):279-85. PubMed ID: 11760487
[TBL] [Abstract][Full Text] [Related]
36. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
Haber P; Moro PL; Cano M; Lewis P; Stewart B; Shimabukuro TT
Vaccine; 2015 Apr; 33(16):1987-92. PubMed ID: 25678241
[TBL] [Abstract][Full Text] [Related]
37. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
Martin D; Menschik D; Bryant-Genevier M; Ball R
Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
[TBL] [Abstract][Full Text] [Related]
38. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
McNeil MM; Arana J; Stewart B; Hartshorn M; Hrncir D; Wang H; Lamias M; Locke M; Stamper J; Tokars JI; Engler RJ
Vaccine; 2012 Mar; 30(14):2421-6. PubMed ID: 22310205
[TBL] [Abstract][Full Text] [Related]
39. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.
Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
Vaccine; 2012 Apr; 30(20):3053-60. PubMed ID: 22425787
[TBL] [Abstract][Full Text] [Related]
40. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
